| Postoperative Complication After Free Flap Reconstruction for Head and Neck Cancer (NCT04326088) | Chang Gung Memorial Hospital | 2018-04-01 |
| An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck (NCT03386838) | Bristol-Myers Squibb | 2018-03-28 |
| Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy (NCT03463161) | University of Chicago | 2018-03-23 |
| New MRI Biomarkers in Head and Neck Cancers (NCT03483337) | Memorial Sloan Kettering Cancer Center | 2018-03-16 |
| CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors (NCT03511391) | University Hospital, Ghent | 2018-03-09 |
| Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx (NCT03418792) | UNC Lineberger Comprehensive Cancer Center | 2018-03-08 |
| Anti-platelet + Pembro for H&N Tumors (NCT03245489) | Medical University of South Carolina | 2018-03-06 |
| Two Different Physiotherapy Programs in Lymphedema Following Head and Neck Cancer Treatment (NCT04286698) | Izmir Bakircay University | 2018-03-05 |
| Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 (NCT03356223) | Centre Leon Berard | 2018-02-05 |
| A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery (NCT03282461) | Dartmouth-Hitchcock Medical Center | 2018-01-24 |
| Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NCT03247712) | Providence Health & Services | 2018-01-15 |
| Evaluation of an Oral Care Programme for Head and Neck Cancer Patients (NCT03481647) | Göteborg University | 2018-01-08 |
| A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment (NCT03332160) | Tactile Medical | 2018-01-02 |
| A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors (NCT03289962) | Genentech, Inc. | 2017-12-21 |
| Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy (NCT03376386) | The Netherlands Cancer Institute | 2017-12-21 |
| Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) (NCT03342352) | Incyte Corporation | 2017-12-15 |
| Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536) | University of Arizona | 2017-12-05 |
| Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study (NCT03380208) | University Health Network, Toronto | 2017-12-01 |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies (NCT03329950) | Celldex Therapeutics | 2017-12-01 |
| Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) (NCT03358472) | Incyte Corporation | 2017-12-01 |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (NCT02997553) | Institut de Cancérologie de Lorraine | 2017-11-29 |
| Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers (NCT03265873) | Fondation Ophtalmologique Adolphe de Rothschild | 2017-11-28 |
| Short Course Radiation Therapy in Palliative Treatment of Head and Neck Cancer (NCT03804073) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2017-11-08 |
| Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics (NCT03266276) | Sunnybrook Health Sciences Centre | 2017-10-10 |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers (NCT03212404) | Checkpoint Therapeutics, Inc. | 2017-09-20 |
| Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer (NCT05269342) | YU LONG HONG | 2017-09-14 |
| Fluorescence Imaging in Head and Neck Cancer (NCT03297957) | Washington University School of Medicine | 2017-09-14 |
| Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps (NCT03349034) | Icahn School of Medicine at Mount Sinai | 2017-09-13 |
| A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma (NCT03207867) | Novartis Pharmaceuticals | 2017-08-28 |
| Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy (NCT03252821) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-08-15 |
| Liquid Biopsy Evaluation and Repository Development at Princess Margaret (NCT03702309) | University Health Network, Toronto | 2017-08-03 |
| The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up (NCT03699098) | Cairo University | 2017-08-01 |
| Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma (NCT03024489) | Mahidol University | 2017-07-19 |
| A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer (NCT03246854) | National Health Research Institutes, Taiwan | 2017-07-18 |
| Proton Re-Irradiation for Recurrent Head and Neck Cancer (NCT03217188) | Memorial Sloan Kettering Cancer Center | 2017-07-10 |
| Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN (NCT03085719) | Dana-Farber Cancer Institute | 2017-06-30 |
| Eating Difficulties in HNC Patients - Influencing Factors and Short and Long Term Impacts on PF and Depression (NCT03883152) | National Taiwan University Hospital | 2017-06-27 |
| Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer (NCT03162224) | MedImmune LLC | 2017-06-26 |
| PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors (NCT03149549) | CytomX Therapeutics | 2017-06-01 |
| Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy (NCT03117946) | Centre Hospitalier Universitaire de Besancon | 2017-05-29 |
| MAGE-A4ᶜ¹º³²T for Multi-Tumor (NCT03132922) | USWM CT, LLC | 2017-05-15 |
| Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy (NCT03114163) | Bristol-Myers Squibb | 2017-05-12 |
| A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study (NCT02841748) | University of Chicago | 2017-05-10 |
| Wound Complications in Head and Neck Surgery (NCT03134976) | University of Michigan | 2017-05-01 |
| Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer (NCT03182959) | University of Arizona | 2017-04-24 |
| Studying Survivorship Care Plans in Head and Neck Cancer (NCT03106090) | Duke University | 2017-04-19 |
| A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer (NCT02990468) | BioMimetix JV, LLC | 2017-04-19 |
| Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers (NCT02994069) | Susanne Arnold | 2017-04-11 |
| Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers (NCT03114501) | M.D. Anderson Cancer Center | 2017-04-11 |
| Comparison of AIRVO High Flow Oxygen Therapy With Standard Care for Prevention of PPCs After Major H&N Surgery (NCT03828578) | Cardiff and Vale University Health Board | 2017-04-01 |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03082534) | University of California, San Diego | 2017-03-28 |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body (NCT03145077) | M.D. Anderson Cancer Center | 2017-03-21 |
| A 3D Analysis of Mandibular Plating Strategies in Oromandibular Reconstruction. (NCT03550053) | University Health Network, Toronto | 2017-03-16 |
| Adaptive Radiotherapy for Head and Neck Cancer (NCT03096808) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| Osteoradionecrosis Rate in Patients Undergoing Radiotherapy for Head and Neck Cancer Treatment. (NCT04009161) | Catholic University of the Sacred Heart | 2017-03-14 |
| Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors (NCT03076255) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-02-24 |
| The Characterisation of RT Caries. (NCT03397823) | King's College London | 2017-02-15 |
| Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study (NCT03245788) | Stanford University | 2017-02-15 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |
| Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer (NCT03294122) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-02-02 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients (NCT03942380) | Christian von Buchwald | 2017-02-01 |
| The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer (NCT05036902) | Singapore General Hospital | 2017-01-23 |
| Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) (NCT03017573) | Institut Curie | 2017-01-06 |
| Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study (NCT03101514) | First Affiliated Hospital of Harbin Medical University | 2017-01-01 |
| Return to Work and Living Healthy After Head and Neck Cancer (NCT03065634) | University of Leipzig | 2017-01-01 |
| Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients (NCT02906800) | Assistance Publique - Hôpitaux de Paris | 2017-01-01 |
| Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer (NCT02794675) | Case Comprehensive Cancer Center | 2016-12-21 |
| Intraoperative Evaluation Using ICG and SPY Fluorescence to Prevent Wound Complications in Head and Neck Surgery. (NCT03345732) | University Health Network, Toronto | 2016-12-08 |
| Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area (NCT02920216) | Institut de Cancérologie de Lorraine | 2016-12-06 |
| Nutrition and Quality of Life of Patients With Head and Neck Carcinoma After Radiotherapy (NCT02789267) | University Hospital, Caen | 2016-12-01 |
| Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02823574) | Bristol-Myers Squibb | 2016-11-08 |
| Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity (NCT02919683) | Dana-Farber Cancer Institute | 2016-11-01 |
| Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer (NCT02965001) | Rigshospitalet, Denmark | 2016-11-01 |
| Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Retrospective Analysis (NCT03991533) | AZ Sint-Jan AV | 2016-11-01 |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375) | Emory University | 2016-10-24 |
| Mouth Opening, Prevention, Education, Nutrition (OPEN) (NCT03979924) | Institut du Cancer de Montpellier - Val d'Aurelle | 2016-10-20 |
| Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02741570) | Bristol-Myers Squibb | 2016-10-05 |
| Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer (NCT02923570) | Memorial Sloan Kettering Cancer Center | 2016-10-03 |
| Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy (NCT03640195) | Chang Gung Memorial Hospital | 2016-10-01 |
| MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers (NCT02989064) | Adaptimmune | 2016-10-01 |
| Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema (NCT02946021) | Tactile Medical | 2016-10-01 |
| Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors (NCT02903914) | Incyte Corporation | 2016-09-14 |
| Improving Evidence-Based Care for Cancer Patients (NCT03207594) | Medical University of South Carolina | 2016-09-01 |
| The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors (NCT03302676) | Odense University Hospital | 2016-09-01 |
| Efficacy of ONS Supplementation in HNC Outpatient Under Treatment (NCT03688646) | National Cancer Institute, Malaysia | 2016-09-01 |
| Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies (NCT05995821) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-25 |
| Evaluating the Use of an Informational Head and Neck Cancer Website. (NCT04268329) | University of Illinois at Chicago | 2016-08-16 |
| Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers (NCT02442739) | Cedars-Sinai Medical Center | 2016-08-15 |
| A Pharmacokinetic Study of Nutri-PEITC Jelly in Head and Neck Cancer Survivors (NCT03700983) | Dental Innovation Foundation Under Royal Patronage | 2016-08-06 |
| Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (NCT02906943) | University Health Network, Toronto | 2016-08-01 |
| Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer (NCT02879968) | Prince of Songkla University | 2016-08-01 |
| Panitumumab IRDye800 Optical Imaging Study (NCT02415881) | Eben Rosenthal | 2016-08-01 |
| International Nutrition Audit in FORegut TuMors (NCT02829489) | University of Alberta | 2016-07-26 |
| Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck (NCT02792322) | Mayo Clinic | 2016-07-11 |
| A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) (NCT02576665) | Tocagen Inc. | 2016-07-01 |
| Regional Anaesthesia and Substance P in Head and Neck Cancer (NCT03081897) | Charite University, Berlin, Germany | 2016-07-01 |
| Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients (NCT02926573) | Washington University School of Medicine | 2016-06-24 |
| Head and Neck Cancer Treatment Related Dysphagia (NCT02657850) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-09 |
| Acquisition of 3D Facial Geometry of Patients' Scheduled for Radiotherapy Treatment (NCT02930915) | University of East Anglia | 2016-06-01 |
| Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas (NCT02776163) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2016-06-01 |